These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34132167)

  • 1. Naturally circulating pertactin-deficient
    Kroes MM; Miranda-Bedate A; Hovingh ES; Jacobi R; Schot C; Pupo E; Raeven RHM; van der Ark AAJ; van Putten JPM; de Wit J; Mariman R; Pinelli E
    Emerg Microbes Infect; 2021 Dec; 10(1):1358-1368. PubMed ID: 34132167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.
    Hovingh ES; Mariman R; Solans L; Hijdra D; Hamstra HJ; Jongerius I; van Gent M; Mooi F; Locht C; Pinelli E
    Emerg Microbes Infect; 2018 Mar; 7(1):39. PubMed ID: 29559630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.
    Carriquiriborde F; Martin Aispuro P; Ambrosis N; Zurita E; Bottero D; Gaillard ME; Castuma C; Rudi E; Lodeiro A; Hozbor DF
    Front Immunol; 2021; 12():730434. PubMed ID: 34603306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
    Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
    Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertactin-deficient
    Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving nature of
    Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB
    Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small mutations in Bordetella pertussis are associated with selective sweeps.
    van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR
    PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.
    Zeddeman A; van Gent M; Heuvelman CJ; van der Heide HG; Bart MJ; Advani A; Hallander HO; Wirsing von Konig CH; Riffelman M; Storsaeter J; Vestrheim DF; Dalby T; Krogfelt KA; Fry NK; Barkoff AM; Mertsola J; He Q; Mooi F
    Euro Surveill; 2014 Aug; 19(33):. PubMed ID: 25166348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.
    Hovingh ES; van Gent M; Hamstra HJ; Demkes M; Mooi FR; Pinelli E
    PLoS One; 2017; 12(1):e0170027. PubMed ID: 28076445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
    Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
    Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
    Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
    Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells.
    Stefanelli P; Fazio C; Fedele G; Spensieri F; Ausiello CM; Mastrantonio P
    New Microbiol; 2009 Apr; 32(2):159-66. PubMed ID: 19579693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape.
    Jayasundara D; Lee E; Octavia S; Lan R; Tanaka MM; Wood JG
    Epidemics; 2020 Jun; 31():100388. PubMed ID: 32387895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France.
    Bodilis H; Guiso N
    Emerg Infect Dis; 2013 Mar; 19(3):471-4. PubMed ID: 23621904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.